欧盟 -
保加利亚文 -
EMA (European Medicines Agency)
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - Дислипидемиите - Липидни модифициращи агенти - indicated to reduce cardiovascular risk as an adjunct to statin therapy.